65797-53-7Relevant articles and documents
Indolyl derivatives as liver-X-receptor (LXR) modulators
-
Page/Page column 18, (2008/06/13)
The invention relates to compounds of formula (I): and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof, wherein R1, R2, R3, R4, R5, R6, A, m, n and p are defined as in claim 1. These compounds can be used as pharmaceutical compositions for the treatment of, for example, diabetes.